178 related articles for article (PubMed ID: 1904040)
41. The effect of season on the circulating concentrations of anterior pituitary, ovarian and adrenal cortex hormones and hormone binding proteins in the subarctic area; evidence of increased activity of the pituitary-ovarian axis in spring.
Kauppila A; Pakarinen A; Kirkinen P; Mäkilä U
Gynecol Endocrinol; 1987 Jun; 1(2):137-50. PubMed ID: 3140579
[TBL] [Abstract][Full Text] [Related]
42. The role of sex hormones in the mechanism of inhibited LH release in female patients with anorexia nervosa.
Baranowska B; Zgliczyński S
Acta Endocrinol (Copenh); 1982 Mar; 99(3):334-8. PubMed ID: 6803484
[TBL] [Abstract][Full Text] [Related]
43. LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.
Cirkel U; Schweppe KW; Ochs H; Hanker JP; Schneider HP
Arch Gynecol Obstet; 1989; 246(3):139-51. PubMed ID: 2515811
[TBL] [Abstract][Full Text] [Related]
44. Does cyclosporin A influence sex hormone level?
Schmidt JB; Gebhart W; Kopsa H; Spona J
Exp Clin Endocrinol; 1986 Dec; 88(2):207-11. PubMed ID: 3556410
[TBL] [Abstract][Full Text] [Related]
45. Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase.
Lemay A; Sandow J; Bureau M; Maheux R; Fontaine JY; Mérat P
Fertil Steril; 1988 Mar; 49(3):410-7. PubMed ID: 3125068
[TBL] [Abstract][Full Text] [Related]
46. [Specifics of hormonal and energy balance in patients with hyperplasia and endometrial neoplasia with metabolic syndrome in the background].
Chernyshova AL; Kolomiets LA; Bochkarëva NV; Kondakova IV
Vopr Onkol; 2013; 59(1):65-71. PubMed ID: 23814828
[TBL] [Abstract][Full Text] [Related]
47. Endocrinologic features of oligomenorrheic adolescent girls.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1986 Nov; 46(5):852-7. PubMed ID: 3096784
[TBL] [Abstract][Full Text] [Related]
48. Effect of gestrinone in endometriosis tissue and endometrium.
Kauppila A; Isomaa V; Rönnberg L; Vierikko P; Vihko R
Fertil Steril; 1985 Oct; 44(4):466-70. PubMed ID: 2996949
[TBL] [Abstract][Full Text] [Related]
49. Genetic variant of luteinizing hormone: impact on gonadal steroid sex hormones in women.
Hill M; Huhtaniemi IT; Hampl R; Stárka L
Physiol Res; 2001; 50(6):583-7. PubMed ID: 11829319
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the efficacy of subcutaneous and nasal spray buserelin treatment in suppression of testicular steroidogenesis in men with prostate cancer.
Rajfer J; Handelsman DJ; Crum A; Steiner B; Peterson M; Swerdloff RS
Fertil Steril; 1986 Jul; 46(1):104-10. PubMed ID: 3087785
[TBL] [Abstract][Full Text] [Related]
51. Low-dose GnRH agonist therapy for the management of endometriosis.
Uemura T; Shirasu K; Katagiri N; Asukai K; Suzuki T; Suzuki N; Osada H; Hiroshi M
J Obstet Gynaecol Res; 1999 Oct; 25(5):295-301. PubMed ID: 10533322
[TBL] [Abstract][Full Text] [Related]
52. Treatment with a luteinising hormone-releasing hormone analogue (Buserelin) in danazol-resistant endometriosis patients.
Franssen AM; Rolland R; Chadha DR; Willemsen WN; Vemer HM
Eur J Obstet Gynecol Reprod Biol; 1986 Dec; 23(5-6):379-86. PubMed ID: 3100357
[TBL] [Abstract][Full Text] [Related]
53. Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin.
Franssen AM; Kauer FM; Chadha DR; Zijlstra JA; Rolland R
Fertil Steril; 1989 Mar; 51(3):401-8. PubMed ID: 2522063
[TBL] [Abstract][Full Text] [Related]
54. Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
Golland IM; Vaughan-Williams CA; Shalet SM; Laing I; Elstein M
Acta Endocrinol (Copenh); 1990 Oct; 123(4):405-10. PubMed ID: 2146853
[TBL] [Abstract][Full Text] [Related]
55. Endocrine effects of danazol in the treatment of endometriosis.
Bevan JR; Dowsett M; Jeffcoate SL
Br J Obstet Gynaecol; 1984 Feb; 91(2):160-6. PubMed ID: 6538094
[TBL] [Abstract][Full Text] [Related]
56. Smoking effects on the hormonal balance of fertile women.
Berta L; Frairia R; Fortunati N; Fazzari A; Gaidano G
Horm Res; 1992; 37(1-2):45-8. PubMed ID: 1398476
[TBL] [Abstract][Full Text] [Related]
57. Clinical, endocrine, and metabolic effects of two doses of gestrinone in treatment of pelvic endometriosis.
Dawood MY; Obasiolu CW; Ramos J; Khan-Dawood FS
Am J Obstet Gynecol; 1997 Feb; 176(2):387-94. PubMed ID: 9065187
[TBL] [Abstract][Full Text] [Related]
58. Sex hormones, sexual activity and plasma anticonvulsant levels in male epileptics.
Toone BK; Wheeler M; Nanjee M; Fenwick P; Grant R
J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):824-6. PubMed ID: 6413659
[TBL] [Abstract][Full Text] [Related]
59. Longitudinal assessment of changes in reproductive hormones during normal pregnancy.
O'Leary P; Boyne P; Flett P; Beilby J; James I
Clin Chem; 1991 May; 37(5):667-72. PubMed ID: 1827758
[TBL] [Abstract][Full Text] [Related]
60. Gonadotrophin releasing hormone agonist suppressive treatment of ovarian function decreases serum LH-beta and bioactive LH but maintains elevated levels of LH-alpha.
Lemay A; Lourdusamy M
Clin Endocrinol (Oxf); 1991 Mar; 34(3):191-6. PubMed ID: 1709841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
